Phoenix Children’s Joins First Controlled Clinical Trial of Genetic Therapy for Dravet Syndrome - Quiz - MDSpire

Phoenix Children’s Joins First Controlled Clinical Trial of Genetic Therapy for Dravet Syndrome

The first controlled phase 3 trial of a genetic therapy for Dravet syndrome is now underway – with Phoenix Children's as one of 28 sites nationwide.

By
August 13, 2026
4 min

Phoenix Children's Medical Connection

Share

Original Source(s)

Phoenix Children's Medical Connection

Phoenix Children’s Joins First Controlled Clinical Trial of Genetic Therapy for Dravet Syndrome

by
August 13, 2026

Related Content

Frontiers In Pediatrics

Higher admission serum total carbon dioxide is independently associated with early seizure recurrence in children with benign convulsions with mild gastroenteritis

by Ling Zou, Feng Li, Hongyu Li, Zhihong Su
June 16, 2026

Frontiers In Neurology

Transcranial low-intensity pulsed ultrasound in neurological disorders: mechanisms, therapeutic applications, and translational challenges

by Hongbo Cai, Yazhe Wang, Shuhan Che, Zhitao Hou
July 14, 2026

Annals Of Neurology

AI-Driven Mapping of Seizure Spread Patterns